eMedicine Specialties > Radiology > Pediatrics

Hypertrophic Pyloric Stenosis

Author: Janet R Reid, MD, FRCP(C), Associate Professor of Radiology, Section Head of Pediatric Radiology, Children's Hospital of Cleveland Clinic
Contributor Information and Disclosures

Updated: Jun 29, 2007

Introduction

Background

Hypertrophic pyloric stenosis (HPS) is commonly encountered in pediatric practice. The typical infant presents with nonbilious projectile vomiting and dehydration (with hypochloremic metabolic alkalosis) if the diagnosis is delayed. HPS accounts for one third of nonbilious vomiting occurrences in infants and is the most common reason for laparotomy before age 1 year.

Despite its status as a common disease, the cause of HPS is unclear; however, a definite genetic component exists because up to a 5-fold increase in HPS incidence is observed in families in which a sibling or parent has had the disease. Pyloric stenosis and esophageal atresia may coexist.1

Ultrasonography (US) is important in the diagnosis of HPS and has likely contributed to the changing face of the disease, because this modality results in earlier diagnosis and treatment.

Pathophysiology

Full-thickness biopsies in patients with HPS demonstrate both hypertrophy and hyperplasia of the circular muscle layer of the pylorus. No clear pathophysiologic sequence or etiology has been described; however, proposed theories include, among others, abnormal circular muscle innervation, immature ganglion cells, decreased nitric-oxide stimulation of muscle fibers, immature ganglion cells, and abnormal gastrin levels.

Interestingly, pyloromyotomy works by 2 mechanisms: initially, the pyloric channel widens as a result of incising the muscle; afterward, the procedure secondarily induces regression of muscle hypertrophy and, over time, the disease itself.

Frequency

United States

HPS is seen in 2-5 infants per 1000 in North America and accounts for 30% of all patients who present with nonbilious vomiting before age 1 year. The onset of vomiting may occur as early as the first week of life and as late as age 5 months. A striking male preponderance is seen, with a male-to-female ratio of 4-6:1.

International

HPS is more common in the white population; the incidence in the Asian, Indian, and black populations is one third to one fifth lower than the incidence in whites.

Mortality/Morbidity

Deaths resulting from HPS are rare. Morbidity is linked directly to the duration and frequency of the patient's vomiting. Protracted vomiting causes decreased intake and increased loss of essential nutrients and electrolytes, which then results in dehydration and metabolic alkalosis. In a 25-year review of 901 infants with surgically proven HPS, Hulka et al describe a trend toward shorter duration of symptoms, earlier presentation, and a 50% reduction in hypochloremic metabolic alkalosis and dehydration.2 This improving trend is, in part, a result of the accessibility and accuracy of US in the diagnosis of HPS.

Race

HPS is more common in whites and is seen less commonly in black infants or infants of Asian descent.

Sex

Males are significantly more affected than females at a rate of 4-6:1.

Age

HPS is most commonly seen in infants aged 3-6 weeks. The thickness of the circular muscle in HPS parallels the patients' age; those presenting at an older age have a muscle thickness (MT) greater than those who present in the usual age range. Premature infants tend to present at 3-6 weeks from birth — not at 3-6 weeks from the due date — and these infants may have borderline normal MT because they are comparatively smaller. A large epidemiologic study reported that the interval between birth and the onset of symptoms in preterm infants was longer than that in full-term infants.3 HPS is rarely seen in children older than 6 months.

Anatomy

In HPS, the circular muscle layer becomes thickened, which narrows the pyloric channel and elongates the pylorus. During this process, the mucosa becomes redundant and may appear hypertrophic. With elongation and thickening of the muscle, the pylorus deviates upward toward the gallbladder, which serves as a marker, because in HPS, the pylorus can be seen adjacent to the gallbladder and anteromedial to the left kidney. The thickened pylorus narrows the pyloric channel, resulting in gastric outlet obstruction, gastric distention, and retrograde peristalsis in the stomach.

Presentation

HPS is the most common indication for laparotomy in infants and accounts for 30% of patients who present with nonbilious vomiting. Parents may describe the vomiting as occurring with every feeding or intermittent vomiting that may be projectile; the vomiting worsens over time. Bilious vomiting is rare. Workup of the vomiting child first requires a detailed history, followed by a complete physical examination.

In the past and with experience,4,5 the pyloric olive, which represents the thickened and elongated pylorus, was said to be felt by surgeons in up to 80% of patients. Review of the more recent radiologic and surgical literature indicates that the olive currently is felt much less frequently (23% of the time in one reported case series).

The low rate of positive palpation for the pyloric olive may be the result of several factors. Patients present at an earlier age when the olive is smaller; with earlier presentation, the incidences of dehydration, metabolic alkalosis, weight loss, and failure to thrive as manifestations of HPS decrease dramatically.2 Consequently, infants who present at a younger age are better nourished such that abdominal wall fat may obscure palpation of the mass. In addition, the skill of palpation may become lost as more medical school graduates come to rely heavily on US for diagnosis.6

Preferred Examination

The preferred diagnostic test for HPS is a contentious topic, with a wealth of articles that discuss the cost-effectiveness and the changing face of this disease.7,8,9

The first and most important step in patient workup of suspected HPS is a thorough physical examination. If the pyloric olive is felt, the patient may proceed directly to the operating room without imaging.5 However, many surgeons are uncomfortable with this protocol because a false-positive physical examination then leads to a negative laparotomy. Therefore, US is recommended because its sensitivity and specificity are close to 100% for this disease.10,11 If the clinical suspicion for HPS is moderate to high, US is also recommended.

If the vomiting infant is outside the usual age range for HPS or if the clinical suspicion is low, an upper gastrointestinal (UGI) study is recommended because it more effectively rules out other problems such as malrotation and gastroesophageal reflux.9

Some investigators have reported that a UGI study is the most cost-effective study8 (more than US) in the vomiting infant because a negative US often leads to a UGI study to rule out other diagnoses that a focused US evaluation does not detect.9 A second test, such as US, rarely follows a negative UGI study for HPS.8,9 In experienced hands, US is the preferred modality in the workup of any vomiting infant. The technique includes feeding glucose water to the baby, which often improves visualization of the pylorus and, in the case of a negative study, allows continuous observation of the gastroesophageal junction to diagnose reflux. The radiologist's skill and clinical suspicion ultimately determine which test is appropriate.

Limitations of Techniques

US has high sensitivity, specificity, and accuracy in the diagnosis of HPS. However, errors in diagnosis do occur and relate to the following:

False negatives

Operator inexperience: The pylorus may not be identified.

Distended formula and gas-filled stomach: These cause the pylorus to fold backward on itself such that it may remain hidden behind the stomach. The overdistended antrum may be mistaken for the pylorus; in such cases and in any infant whose pylorus is not visualized on US, place a nasogastric tube and withdraw the gastric secretions.

MT increases with patient size. Borderline measurements are seen early in the disease and with premature infants. Some clinicians advocate observation and then repeating the US study in 2-3 days to confirm the diagnosis if the patient is stable and is not dehydrated.

False positives

Pylorospasm: The normal pylorus opens at least once every 15 minutes. Pylorospasm is a dynamic process that changes over time. The thickened muscle and elongated pylorus should be fixed.

Postoperative appearance: Symptoms may take time to clear and, therefore, so do the abnormalities on US. US may show HPS (thickened MT) for up to 12 weeks following pyloromyotomy. In these cases, a UGI study may provide more information than US to rule out incomplete myotomy.

Differential Diagnoses

Midgut Volvulus

Other Problems to Be Considered

Malrotation, with or without midgut volvulus
Antral polyp
Gastric duplication
Focal foveolar hyperplasia
Pylorospasm

More on Hypertrophic Pyloric Stenosis

Overview: Hypertrophic Pyloric Stenosis
Imaging: Hypertrophic Pyloric Stenosis
Follow-up: Hypertrophic Pyloric Stenosis
Multimedia: Hypertrophic Pyloric Stenosis
References

References

  1. Magilner AD. Esophageal atresia and hypertrophic pyloric stenosis: sequential coexistence of disease (case report). AJR Am J Roentgenol. Aug 1986;147(2):329-30. [Medline][Full Text].

  2. Hulka F, Campbell TJ, Campbell JR, Harrison MW. Evolution in the recognition of infantile hypertrophic pyloric stenosis. Pediatrics. Aug 1997;100(2):E9. [Medline][Full Text].

  3. Schechter R, Torfs CP, Bateson TF. The epidemiology of infantile hypertrophic pyloric stenosis. Paediatr Perinat Epidemiol. Oct 1997;11(4):407-27. [Medline].

  4. Hernanz-Schulman M. Infantile hypertrophic pyloric stenosis. Radiology. May 2003;227(2):319-31. [Medline][Full Text].

  5. White MC, Langer JC, Don S, DeBaun MR. Sensitivity and cost minimization analysis of radiology versus olive palpation for the diagnosis of hypertrophic pyloric stenosis. J Pediatr Surg. Jun 1998;33(6):913-7. [Medline].

  6. Chen EA, Luks FI, Gilchrist BF, Wesselhoeft CW Jr, DeLuca FG. Pyloric stenosis in the age of ultrasonography: fading skills, better patients?. J Pediatr Surg. Jun 1996;31(6):829-30. [Medline].

  7. Mandell GA, Wolfson PJ, Adkins ES, et al. Cost-effective imaging approach to the nonbilious vomiting infant. Pediatrics. Jun 1999;103(6 Pt 1):1198-202. [Medline][Full Text].

  8. Olson AD, Hernandez R, Hirschl RB. The role of ultrasonography in the diagnosis of pyloric stenosis: a decision analysis. J Pediatr Surg. 33(5);1998 May:676-81. [Medline].

  9. Hulka F, Campbell JR, Harrison MW, Campbell TJ. Cost-effectiveness in diagnosing infantile hypertrophic pyloric stenosis. J Pediatr Surg. Nov 1997;32(11):1604-8. [Medline].

  10. Hernanz-Schulman M, Sells LL, Ambrosino MM, et al. Hypertrophic pyloric stenosis in the infant without a palpable olive: accuracy of sonographic diagnosis. Radiology. Dec 1994;193(3):771-6. [Medline][Full Text].

  11. Stunden RJ, LeQuesne GW, Little KE. The improved ultrasound diagnosis of hypertrophic pyloric stenosis. Pediatr Radiol. 1986;16(3):200-5. [Medline].

  12. Sargent SK, Foote SL, Mooney DP, Shorter NA. The posterior approach to pyloric sonography. Pediatr Radiol. Apr 2000;30(4):256-7. [Medline].

  13. Teele RL, Smith EH. Ultrasound in the diagnosis of idiopathic hypertrophic pyloric stenosis. N Engl J Med. May 19 1977;296(20):1149-50. [Medline].

  14. Aldridge RD, MacKinlay GA, Aldridge RB. Choice of incision: the experience and evolution of surgical management of infantile hypertrophic pyloric stenosis. J Laparoendosc Adv Surg Tech A. Feb 2007;17(1):131-6. [Medline].

  15. Alvarez SM, Poelstra BA, Burd RS. Evaluation of a Bayesian decision network for diagnosing pyloric stenosis. J Pediatr Surg. Jan 2006;41(1):155-61; discussion 155-61. [Medline].

  16. Blumer SL, Zucconi WB, Cohen HL, Scriven RJ, Lee TK. The vomiting neonate: a review of the ACR appropriateness criteria and ultrasound's role in the workup of such patients. Ultrasound Q. Sep 2004;20(3):79-89. [Medline].

  17. Cohen HL, Blumer SL, Zucconi WB. The sonographic double-track sign: not pathognomonic for hypertrophic pyloric stenosis; can be seen in pylorospasm. J Ultrasound Med. May 2004;23(5):641-6. [Medline].

  18. Cohen HL, Schechter S, Mestel AL, Eaton DH, Haller JO. Ultrasonic "double track" sign in hypertrophic pyloric stenosis. J Ultrasound Med. Mar 1987;6(3):139-43. [Medline].

  19. Helton KJ, Strife JL, Warner BW, Byczkowski TL, Donovan EF. The impact of a clinical guideline on imaging children with hypertrophic pyloric stenosis. Pediatr Radiol. Sep 2004;34(9):733-6. [Medline].

  20. Hernanz-Schulman M, Dinauer P, Ambrosino MM, Polk DB, Neblett WW 3rd. The antral nipple sign of pyloric mucosal prolapse: endoscopic correlation of a new sonographic observation in patients with pyloric stenosis. J Ultrasound Med. Apr 1995;14(4):283-7. [Medline].

  21. Kirks DR, Griscom NT, eds. Gastrointestinal tract. Practical Pediatric Imaging: Diagnostic Radiology of Infants and Children. 3rd ed. Philadelphia, Pa: Lippincott-Raven; 1998:902-4.

  22. Kottamasu SR. The stomach. In: Stringer DA, Babyn PS, eds. Pediatric Gastrointestinal Imaging and Intervention. 2nd ed. Hamilton, Ontario, Canada: B.C. Decker, Inc; 2000:275-80.

  23. Okorie NM, Dickson JA, Carver RA, Steiner GM. What happens to the pylorus after pyloromyotomy?. Arch Dis Child. Nov 1988;63(11):1339-41. [Medline].

  24. Oue T, Puri P. Abnormalities of elastin and elastic fibers in infantile hypertrophic pyloric stenosis. Pediatr Surg Int. 1999;15(8):540-2. [Medline].

  25. Oue T, Puri P. Smooth muscle cell hypertrophy versus hyperplasia in infantile hypertrophic pyloric stenosis. Pediatr Res. Jun 1999;45(6):853-7. [Medline][Full Text].

  26. Rohrschneider WK, Mittnacht H, Darge K, Tröger J. Pyloric muscle in asymptomatic infants: sonographic evaluation and discrimination from idiopathic hypertrophic pyloric stenosis. Pediatr Radiol. Jun 1998;28(6):429-34. [Medline].

  27. Sorantin E, Fotter R, Schimpl G. Reversible portal venous gas in hypertrophic pyloric stenosis: detection by ultrasound. J Ultrasound Med. Sep 1995;14(9):699-701. [Medline].

  28. Spevak MR, Ahmadjian JM, Kleinman PK, et al. Sonography of hypertrophic pyloric stenosis: frequency and cause of nonuniform echogenicity of the thickened pyloric muscle. AJR Am J Roentgenol. Jan 1992;158(1):129-32. [Medline][Full Text].

  29. Taylor MT, Lawson KR, Ignatenko NA, et al. Sulindac sulfone inhibits K-ras-dependent cyclooxygenase-2 expression in human colon cancer cells. Cancer Res. Dec 1 2000;60(23):6607-10. [Medline][Full Text].

Further Reading

Keywords

idiopathic hypertrophic pyloric stenosis, infantile hypertrophic pyloric stenosis, pyloric stenosis, HPS, IHPS, projectile vomiting, nonbilious infantile projectile vomiting

Contributor Information and Disclosures

Author

Janet R Reid, MD, FRCP(C), Associate Professor of Radiology, Section Head of Pediatric Radiology, Children's Hospital of Cleveland Clinic
Janet R Reid, MD, FRCP(C) is a member of the following medical societies: American Association for Women Radiologists, American Society of Neuroradiology, Ohio State Medical Association, Radiological Society of North America, Royal College of Physicians and Surgeons of Canada, and Society for Pediatric Radiology
Disclosure: Nothing to disclose.

Medical Editor

Robert J Starshak, MD, Medical Director, Assistant Clinical Professor, Department of Radiology, Medical College of Wisconsin, Falls Medical Group
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

David A Stringer, BSc, MBBS, FRCR, FRCPC, Professor, National University of Singapore; Head, Diagnostic Imaging, KK Women's and Children's Hospital, Singapore
David A Stringer, BSc, MBBS, FRCR, FRCPC is a member of the following medical societies: British Columbia Medical Association, Canadian Association of Radiologists, European Society of Paediatric Radiology, Ontario Medical Association, Radiological Society of North America, Royal College of Physicians and Surgeons of Canada, Royal College of Radiologists, and Society for Pediatric Radiology
Disclosure: None None None

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

John Karani, MBBS, FRCR, Consulting Staff, Department of Radiology, King's College Hospital, London
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.